CHTR vs IMA · P/E 11, rev $55.09B vs rev $9.2M
Charter Communications Inc (CHTR) versus ImageneBio, Inc. (IMA) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. IMA currently screens at market cap $64.7M.
Not investment advice. Open the CHTR and IMA stock pages for the full models.
Not investment advice.